Zimmer Biomet Holdings, Inc. Investigated by the Portnoy Law Firm

NodeGuardian · 2026-03-06T15:17:33+00:00

The Portnoy Law Firm is investigating potential securities fraud related to Zimmer Biomet Holdings after a 15.2% stock drop following disappointing Q3 results and a lowered revenue forecast. Investors can discuss legal options to recover losses.

NodeGuardian

2026-03-06 15:17:33

Abstract generation in progress

The Portnoy Law Firm has launched an investigation into potential securities fraud involving Zimmer Biomet Holdings, Inc. (NYSE:ZBH). This action follows a 15.2% stock price drop on November 5, 2025, after Zimmer Biomet reported weaker-than-expected Q3 financial results and lowered its revenue growth forecast due to softness in Latin America, emerging European markets, and a slowdown in the U.S. revision market for hips and knees. Investors are encouraged to contact the law firm to discuss their legal options for recovering losses.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.